3-119812708-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_003889.4(NR1I2):​c.542G>A​(p.Gly181Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)

Consequence

NR1I2
NM_003889.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.317
Variant links:
Genes affected
NR1I2 (HGNC:7968): (nuclear receptor subfamily 1 group I member 2) This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.052084327).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NR1I2NM_003889.4 linkuse as main transcriptc.542G>A p.Gly181Asp missense_variant 5/9 ENST00000393716.8 NP_003880.3 O75469-1
NR1I2NM_022002.3 linkuse as main transcriptc.659G>A p.Gly220Asp missense_variant 5/9 NP_071285.1 O75469-7F1D8P9
NR1I2NM_033013.3 linkuse as main transcriptc.520-89G>A intron_variant NP_148934.1 O75469-4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NR1I2ENST00000393716.8 linkuse as main transcriptc.542G>A p.Gly181Asp missense_variant 5/91 NM_003889.4 ENSP00000377319.3 O75469-1J3KPQ3
NR1I2ENST00000337940.4 linkuse as main transcriptc.659G>A p.Gly220Asp missense_variant 5/91 ENSP00000336528.4 O75469-7
NR1I2ENST00000466380.6 linkuse as main transcriptc.520-89G>A intron_variant 1 ENSP00000420297.2 O75469-4H0Y8E2
NR1I2ENST00000493757.1 linkuse as main transcriptn.674G>A non_coding_transcript_exon_variant 2/62

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 19, 2024The c.542G>A (p.G181D) alteration is located in exon 5 (coding exon 4) of the NR1I2 gene. This alteration results from a G to A substitution at nucleotide position 542, causing the glycine (G) at amino acid position 181 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.0012
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
11
DANN
Benign
0.80
DEOGEN2
Benign
0.062
.;.;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.056
N
LIST_S2
Benign
0.56
T;T;T
M_CAP
Benign
0.074
D
MetaRNN
Benign
0.052
T;T;T
MetaSVM
Benign
-0.48
T
MutationAssessor
Benign
0.69
.;.;N
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.11
N;N;.
REVEL
Benign
0.17
Sift
Benign
0.29
T;T;.
Sift4G
Benign
0.45
T;T;.
Polyphen
0.0010
.;.;B
Vest4
0.21
MutPred
0.32
Gain of glycosylation at S179 (P = 0.0704);.;Gain of glycosylation at S179 (P = 0.0704);
MVP
0.38
MPC
0.11
ClinPred
0.060
T
GERP RS
-1.5
Varity_R
0.044
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr3-119531555; COSMIC: COSV61978105; COSMIC: COSV61978105; API